XML 22 R11.htm IDEA: XBRL DOCUMENT v3.21.1
Fair Value of Financial Instruments
6 Months Ended
Mar. 31, 2021
Fair Value Disclosures [Abstract]  
Fair Value of Financial Instruments

4.   Fair Value of Financial Instruments

The Company’s financial instruments generally include cash and cash equivalents, short-term investments, trade accounts, notes receivable and accounts payable.  Due to the short-term maturities of cash and cash equivalents, trade accounts, notes receivable and accounts payable, the carrying amounts of these financial instruments are deemed to approximate their fair value on the respective balance sheet dates.  The valuation technique used to measure the fair value of the contingent consideration was derived from models utilizing market observable inputs.  

The Company measures its short-term investments and contingent consideration at fair value on a recurring basis.

The following tables present the fair value of the Company’s short-term investments and contingent consideration by valuation hierarchy and input (in thousands):

 

 

 

 

As of March 31, 2021

 

 

 

Quoted Prices in

Active Markets for

Identical Assets

(Level 1)

 

 

Significant

Other

Observable

(Level 2)

 

 

Significant

Unobservable

(Level 3)

 

 

Totals

 

Short-term investments:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

     Corporate bonds

 

$

3,865

 

 

$

 

 

$

 

 

$

3,865

 

Total assets

 

$

3,865

 

 

$

 

 

$

 

 

$

3,865

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Contingent consideration:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current portion

 

 

 

 

 

 

 

 

(2,324

)

 

 

(2,324

)

Non-current portion

 

 

 

 

 

 

 

 

(7,720

)

 

 

(7,720

)

Total liabilities

 

$

 

 

$

 

 

$

(10,044

)

 

$

(10,044

)

 

 

 

As of September 30, 2020

 

 

 

Quoted Prices in

Active Markets for

Identical Assets

(Level 1)

 

 

Significant

Other

Observable

(Level 2)

 

 

Significant

Unobservable

(Level 3)

 

 

Totals

 

Non-current contingent consideration

 

$

 

 

$

 

 

$

(10,962

)

 

$

(10,962

)

 

The following table summarizes changes in the fair value of the Company’s Level 3 financial instruments for the six months ended March 31, 2021:

 

Balance at October 1, 2020

$

10,962

 

Fair value adjustments

 

(697

)

Balance at December 31, 2020

 

10,265

 

Fair value adjustments

 

(221

)

Balance at March 31, 2021

$

10,044

 

 

Adjustments to the fair value of the contingent consideration are based on Monte Carlo simulations or the probability-weighted expected return method utilizing inputs which include market comparable information and management assessments regarding potential future scenarios.  The Company believes its estimates and assumptions are reasonable, however, there is significant judgment involved.